Can Blood Biomarkers Predict Clinical Response to Azithromycin in Cystic Fibrosis Patients?
Although azithromycin can lower pulmonary exacerbation (PEx) risk in patients with cystic fibrosis (CF), it does not help all patients....
Viral Respiratory Tract Infections in Young CF Children Usually Mild, Study Found
Viral respiratory tract infections in young children with cystic fibrosis tend to be mild and not require hospitalization, a study found....
Screening for cystic fibrosis-related diabetes and prediabetes: Evaluating 1,5-anhydroglucitol, fruc
Researchers examined whether alternate glycemic markers—hemoglobin A1c (HbA1c), 1,5-anhydroglucitol (1,5AG), fructosamine (FA), and...
Hexoskin Smart Shirt Can Accurately Assess Respiratory Function, May Be Tool in CF, Study Shows
Using a simple shirt — a smart one — is closer to becoming a common method to measure lung function in patients with respiratory...
5,000 Expected to Attend Cystic Fibrosis Conference, NACFC 2019, in Nashville
The Western Hemisphere’s largest gathering of experts in cystic fibrosis gets underway later this month in Nashville, Tennessee — site of...
New Clinical Tool Predicts 1- and 2-Year Mortality in Cystic Fibrosis
Researchers in Canada have developed a novel clinical tool that uses patients’ overall health status and the risk for intermittent shock...